Skip to main content

Table 1 Baseline characteristics and demographical features of the study population

From: The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation

Variables sinus rhythm (n = 78) AF recurrence (n = 47) P value
Age (years) 61.5 (13.25) 63.0 (15.0) 0.717
Gender (female) 38 (48.7%) 18 (38.3%) 0.256
Body mass index (kg/m2) 24.7 ± 2.9 26.1 ± 3.1 0.016*
Hypertension 47 (60.3%) 34 (72.3%) 0.171
Diabetes mellitus 9 (11.5%) 14 (29.8%) 0.011*
Coronary artery disease 19 (24.4%) 9 (19.1%) 0.499
Stroke 13 (16.7%) 8 (17.0%) 0.959
AF duration (months) 12.0 (31.25) 24.0 (48.0) 0.035*
Procedure time (minnutes) 240 (60.0) 240 (119.0) 0.969
CHA2DS2-VASc score 2.0 (2.0) 2.0 (2.0) 0.172
HATCH score 0.95 ± 0.89 1.09 ± 0.93 0.418
Hemoglobin (g/L) 137.9 ± 21.6 137.1 ± 16.2 0.847
AST (U/L) 21 (10.25) 23 (8.0) 0.578
Serum creatinine (umol/L) 83.0 ± 18.3 86.6 ± 19.1 0.301
Uric acid (umol/L) 309.3 ± 84.5 325.2 ± 96.4 0.336
WBC (×109/L) 5.40 (1.91) 5.69 (2.35) 0.359
Monocyte (× 109/L) 0.32 (0.13) 0.35 (0.15) 0.007*
LDL cholesterol (mmol/L) 2.42 (1.18) 2.36 (0.88) 0.521
HDL cholesterol (mmol/L) 1.33 (0.54) 1.09 (0.40) 0.002*
Monocyte/HDL ratio 6.34 (3.39) 8.29 (4.99) 0.000*
Cystatin C (mg/L) 0.8 (0.39) 0.8 (0.30) 0.165
D-Dimer (mg/L) 0.27 (0.21) 0.27 (0.14) 0.008*
LAD (mm) 34 (6.0) 38 (6.0) 0.000*
LVEF (%) 62 (1.25) 61 (3.0) 0.205
Follow-up duration (months) 22 (20.25) 19 (12.0) 0.165
  1. *P < 0.05